Skip to main content
. 2021 Aug 20;95(10):3205–3221. doi: 10.1007/s00204-021-03140-x

Fig. 8.

Fig. 8

Results of transport studies presented as cumulative transported amounts of fluroxypyr-meptyl in a AP–BL direction and b BL–AP direction and fluroxypyr in c AP–BL direction and d BL–AP direction. Transport studies in both directions were carried out with 1 mg/L fluroxypyr-meptyl, mix 2A (1 mg/L fluroxypyr-meptyl + 0.1 mg/L Rhodacal® 60/BE, 0.2 mg/L Emulsogen® EL400), product 2 (containing 1 mg/L fluroxypyr-meptyl) and mix 2B (1 mg/L abamectin + 120 mg/L Rhodacal® 60/BE, 120 mg/L Emulsogen® EL400, 160 mg/L Solgad® 150 ULN). All concentrations were related to the measured start concentrations of the solutions and are given as relative values in percent. Data are presented as mean values ± SD of n = 2 independent experiments for AP–BL direction and n = 3 independent experiments for BL–AP direction. Statistical analysis was done by a linear mixed-effects ANOVA (α = 0.05) followed by a post hoc comparison with holm adjustment of the estimated curves of mix 2A, product 2 and mix 2B with the curve of the active ingredient fluroxypyr-meptyl. Statistical significance at α = 0.05 level compared to reference compound is indicated by asterisks (*)